Longitudinal Patient‐Reported Voice Quality in Early‐Stage Glottic Cancer
Otolaryngology–Head and Neck Surgery · 2023
DOI: 10.1002/ohn.263 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2023. Verfasst von Maarten C Dorr und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlan…. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Laser Therapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Patient‐reported voice quality is an important outcome during counseling in early‐stage glottic cancer. However, there is a paucity of adequate longitudinal studies concerning voice outcomes. This study aimed to investigate longitudinal trajectories for patient‐reported voice quality and associated risk factors for treatment modalities such as transoral CO 2 laser microsurgery, single vocal cord irradiation, and local radiotherapy. Study Design A longitudinal observational cohort study.
Setting
Tertiary cancer center.
Methods
Patients treated for Tcis‐T1b, N0M0 glottic cancer were included in this study (N = 294). The Voice Handicap Index was obtained at baseline and during follow‐up (N = 1944). Mixed‐effects models were used for investigating the different trajectories for patient‐reported voice quality.
Results
The mean follow‐up duration was 43.4 (SD 21.5) months. Patients received transoral CO 2 laser microsurgery (57.8%), single vocal cord irradiation (24.5%), or local radiotherapy (17.5%). A steeper improvement during the first year after treatment for single vocal cord irradiation (−15.7) and local radiotherapy (−12.4) was seen, compared with a more stable trajectory for laser surgery (−6.1). All treatment modalities showed equivalent outcomes during long‐term follow‐up. Associated risk factors for different longitudinal trajectories were age, tumor stage, and comorbidity.
Conclusion
Longitudinal patient‐reported voice quality after treatment for early‐stage glottic cancer is heterogeneous and nonlinear. Most improvement is seen during the first year of follow‐up and differs between treatment modalities. No clinically significant differences in long‐term trajectories were found. Insight into longitudinal trajectories can enhance individual patient counseling and provide the foundation for an individualized dynamic prediction model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
- Department of Biostatistics and Epidemiology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
ORCID-Profile: Maarten C Dorr
Zitieren
APA
Dorr, M. C., Sewnaik, A., Andrinopoulou, E., Berzenji, D., Dronkers, E. A. C., Bernard, S. E., Hoesseini, A., Tans, L., Rizopoulos, D., Baatenburg de Jong, R. J., & Offerman, M. P. J. (2023). Longitudinal Patient‐Reported Voice Quality in Early‐Stage Glottic Cancer. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.263
Vancouver
Dorr MC, Sewnaik A, Andrinopoulou E, Berzenji D, Dronkers EAC, Bernard SE, et al. Longitudinal Patient‐Reported Voice Quality in Early‐Stage Glottic Cancer. Otolaryngology–Head and Neck Surgery. 2023. doi:10.1002/ohn.263
BibTeX
@article{Dorr2023,
author = {Dorr, Maarten C and Sewnaik, Aniel and Andrinopoulou, Elrozy and Berzenji, Diako and Dronkers, Emilie A C and Bernard, Simone E and Hoesseini, Arta and Tans, Lisa and Rizopoulos, Dimitris and Baatenburg de Jong, Robert J and Offerman, Marinella P J},
title = {Longitudinal Patient‐Reported Voice Quality in Early‐Stage Glottic Cancer},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2023},
doi = {10.1002/ohn.263}
}
EUVIMED